InsidersTradesSigma
Track the 亚虹医药 share price and the full insider trade history of the company, a listed equity based in China. Shares are quoted on CN CN, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 亚虹医药 has published 7 insider filings. Market capitalisation: €5.8bn. The latest transaction was filed on 6 March 2026 (Sale). Among the most active insiders: PAN KE. Every trade is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
7 of 7 declarations